General information, not an individual diagnosis. Ask a healthcare professional if you are unsure about your situation.
Anti-Müllerian hormone, or AMH, is a marker of the ovarian reserve of follicles. In a prescribed assessment, the doctor may request a blood test when reduced reserve is suspected or assisted reproduction is being considered.
Ovarian reserve is one part of an assessment, not an answer to every fertility question. The team also considers medical history and selects other tests according to the circumstances.
Ultrasound may help assess ovarian follicles. The French health authority HAS describes using AMH alongside the follicle count to predict a low or excessive response to ovarian stimulation.
However, that HAS assessment does not indicate AMH testing to predict implantation, pregnancy or birth in assisted reproduction. A result therefore cannot guarantee the outcome of the pathway.
In a healthy woman, HAS does not recommend this test to predict spontaneous fertility. Its assessment also says thresholds depend on the method used: ask your doctor to interpret your result in context.
Keep the laboratory report for your appointment and prepare questions: why was this test requested, which other results matter, and which decision should be discussed next with the team?
Sources
Your health review
Review your health
Mon bilan prévention is an appointment to discuss your habits and choose your health priorities. Review the four age groups and practical information.